Consistent with the presence of basal replication stress in cancer cells and the role of RAD51 in dealing with replication stress, some cancer cells overexpress RAD51 [43, 44], making it a potential novel target for anti-cancer therapies [45–47]. Here, RAD51 is linked to cancer.